A groundbreaking clinical trial at the University of Chicago has potentially cured all 12 participants of Type 1 diabetes. The procedure involves transplanting cells on the pancreas - called islet cells - in combination with a new drug to prevent rejection. NBC News’ Anne Thompson has a closer look.